Insider Transactions in Q4 2021 at Neurocrine Biosciences Inc (NBIX)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 14
2021
|
Stephen A Sherwin Director |
SELL
Bona fide gift
|
Direct |
2,000
-7.39%
|
-
|
|
Dec 10
2021
|
Darin Lippoldt Chief Legal Officer |
SELL
Bona fide gift
|
Direct |
120
-0.35%
|
-
|
|
Dec 01
2021
|
Matt Abernethy Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,645
-9.14%
|
$134,890
$82.59 P/Share
|
|
Oct 07
2021
|
Dimitri E. Grigoriadis Chief Research Officer |
SELL
Open market or private sale
|
Direct |
8,000
-4.62%
|
$832,000
$104.8 P/Share
|
|
Oct 07
2021
|
Dimitri E. Grigoriadis Chief Research Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+5.42%
|
$215,000
$43.24 P/Share
|
|
Oct 07
2021
|
Gary A Lyons Director |
SELL
Open market or private sale
|
Direct |
5,000
-2.34%
|
$525,000
$105.06 P/Share
|
|
Oct 04
2021
|
Julie Cooke Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
987
-6.24%
|
$99,687
$101.73 P/Share
|